Early immunosuppression treatment correlates with later de novo donor‐specific antibody development after kidney and pancreas transplantation

Publisher： John Wiley & Sons Inc

E-ISSN： 1399-0012|29|12|1119-1127

ISSN： 0902-0063

Source： CLINICAL TRANSPLANTATION (ELECTRONIC), Vol.29, Iss.12, 2015-12, pp. : 1119-1127

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Results of early treatment for de novo donor‐specific antibodies in pediatric kidney transplant recipients in a cross‐sectional and longitudinal cohort

By  

PEDIATRIC TRANSPLANTATION, Vol. 22, Iss. 2, 2018-03 ,pp. : n/a-n/a

John Wiley & Sons Inc

Access to resources Recommend Favorite

Rates and Determinants of Progression to Graft Failure in Kidney Allograft Recipients With De Novo Donor‐Specific Antibody

By  

AMERICAN JOURNAL OF TRANSPLANTATION, Vol. 15, Iss. 11, 2015-11 ,pp. : 2921-2930

John Wiley & Sons Inc

Access to resources Recommend Favorite

Risk factors for the development of donor‐specific antibodies after pediatric heart transplantation

By  

PEDIATRIC TRANSPLANTATION, Vol. 19, Iss. 8, 2015-12 ,pp. : 906-910

John Wiley & Sons Inc

Access to resources Recommend Favorite

A suspected case of plasma cell‐rich acute renal transplant rejection associated with de novo donor‐specific antibody

By  

NEPHROLOGY, Vol. 20, Iss. S2, 2015-07 ,pp. : 66-69

John Wiley & Sons Inc

Access to resources Recommend Favorite

Clinical impact of preformed donor‐specific denatured class I HLA antibodies after kidney transplantation

By  

CLINICAL TRANSPLANTATION (ELECTRONIC), Vol. 29, Iss. 5, 2015-05 ,pp. : 393-402

John Wiley & Sons Inc

Access to resources Recommend Favorite